Growth Hormone-Releasing Hormone

DRUG5 trials

Sponsors

Stefania La Grutta, MD, Cairo University, Dauntless Pharmaceuticals, Center for Genetic Engineering and Biotechnology (CIGB), in Havana

Conditions

Acute cerebral infarction of ischemic etiologyGrowth Hormone DeficiencyHealthy Volunteer StudySubfertility

Phase 1

Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers

CompletedNCT03031535

Dauntless PharmaceuticalsHealthy Volunteer Study

Start: 2017-01-31End: 2017-03-31Updated: 2017-05-12

Phase 2

Active, not recruitingRPCEC00000214

Center for Genetic Engineering and Biotechnology (CIGB), in HavanaAcute cerebral infarction of ischemic etiology

Start: 2016-09-01Target: 30Updated: 2026-03-30

Phase 3

Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response

Cairo UniversitySubfertility

Start: 2016-06-30Target: 210Updated: 2016-07-06

COURAGE-2 Study

Active, not recruitingRPCEC00000300

Center for Genetic Engineering and Biotechnology (CIGB), in HavanaAcute cerebral infarction of ischemic etiology

Start: 2019-06-03Target: 220Updated: 2026-03-30

Unknown Phase

Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)

CompletedNCT02507245

Stefania La Grutta, MDGrowth Hormone Deficiency

Start: 2014-01-31End: 2015-05-31Updated: 2015-07-23

Related Papers

Combination therapy of Epidermal Growth Factor and Growth Hormone-Releasing Hexapeptide in acute ischemic stroke: a phase I/II non-blinded, randomized clinical trial

Frontiers in Neurology2024-04-041 citations